Physician profile
Baley Petersen
NPI 1043569858
$5,210.29
in general payments reported to CMS, 2019-2025
17 companies · $1,687 in 2025
The $1,687 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.32 · 2020: $181 · 2021: $199 · 2022: $1,004 · 2023: $871 · 2024: $1,220 · 2025: $1,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,005 · Consulting Fee: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,004.64 |
| Consulting Fee | $773.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,064.47 | 2019-2025 | Acuvue |
| Biotissue Holdings INC. | $450.20 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $434.71 | 2023-2025 | Acthar |
| Oyster Point Pharma, INC. | $312.70 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Alcon Vision LLC | $265.41 | 2022-2025 | Tryptyr, Precision7, Eysuvis |
| Abbvie INC. | $253.38 | 2023 | |
| Bausch & Lomb Americas INC. | $251.84 | 2023-2025 | Miebo, Xiidra, Alrex |
| Tarsus Pharmaceuticals, INC. | $247.12 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $229.09 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $216.38 | 2023-2024 | Tecnis Iol, Tecnis Iol |
| Glaukos Corporation | $136.78 | 2024 | Ce-Marked Kxla System |
| Amgen INC. | $119.55 | 2024 | Tepezza |
| Sun Pharmaceutical Industries INC. | $95.76 | 2023 | Cequa |
| Dompe US, INC. | $59.31 | 2022-2025 | Oxervate |
| Harrow Eye, LLC | $39.10 | 2024 | Vevye |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Quidel Corporation | $18.39 | 2021 | |
| Coopervision INC. | $16.10 | 2023 | Myday Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baley Petersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.